Cite
Koh CY, Shih N, Yip CYC, et al. Efficacy and safety of next-generation tick transcriptome-derived direct thrombin inhibitors. Nat Commun. 2021;12(1):6912doi: 10.1038/s41467-021-27275-8.
Koh, C. Y., Shih, N., Yip, C. Y. C., Li, A. W. L., Chen, W., Amran, F. S., Leong, E. J. E., Iyer, J. K., Croft, G., Mazlan, M. I. B., Chee, Y. L., Yap, E. S., Monroe, D. M., Hoffman, M., Becker, R. C., de Kleijn, D. P. V., Verma, V., Gupta, A., Chaudhary, V. K., Richards, A. M., Kini, R. M., & Chan, M. Y. (2021). Efficacy and safety of next-generation tick transcriptome-derived direct thrombin inhibitors. Nature communications, 12(1), 6912. https://doi.org/10.1038/s41467-021-27275-8
Koh, Cho Yeow, et al. "Efficacy and safety of next-generation tick transcriptome-derived direct thrombin inhibitors." Nature communications vol. 12,1 (2021): 6912. doi: https://doi.org/10.1038/s41467-021-27275-8
Koh CY, Shih N, Yip CYC, Li AWL, Chen W, Amran FS, Leong EJE, Iyer JK, Croft G, Mazlan MIB, Chee YL, Yap ES, Monroe DM, Hoffman M, Becker RC, de Kleijn DPV, Verma V, Gupta A, Chaudhary VK, Richards AM, Kini RM, Chan MY. Efficacy and safety of next-generation tick transcriptome-derived direct thrombin inhibitors. Nat Commun. 2021 Nov 25;12(1):6912. doi: 10.1038/s41467-021-27275-8. PMID: 34824278; PMCID: PMC8617063.
Copy
Download .nbib